ESMO 2025 – Dr. Sotiriou on Exceptional Responders

Dr. Christos Sotiriou shares key insights from his ESMO 2025 presentation on exceptional responders in metastatic cancer, exploring molecular and clinical factors that help identify patients who achieve extraordinary outcomes with targeted therapies.